Kliinisen patologian ja oikeuslääketieteen laitos
Department of Pathology and Forensic Medicine

Julkaisut 1999
Publications 1999

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aaltomaa S et al. Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival.
2 Aaltomaa S et al. Alfa-catenin expression has prognostic value in local and locally advanced prostate cancer.
3 Aaltomaa S et al. Expression of cyclins A and D and p21 (waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival .
4 Aaltomaa S et al. Prognostic value and expression of p21 (waf1/cip 1) protein in prostate cancer.
5 Ackermann L et al. Mast cells in psoriatic skin are strongly positive for interferon-gamma.
6 Alafuzoff I et al. Rapidly progressive multifocal leukoencephalopathy with substantial cell-mediated inflammatory response and with cognitive decline of non-Alzheimer type in a 75-year-old female patient.
7 Anttila M et al. Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR.
8 Anttila MA et al. The prognostic significance of p53 expression quantitated by computerized image analysis in epithelial ovarian cancer.
9 Anttila MA et al. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
10 Böhm J et al. Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma.
11 de Villiers E-M et al. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China.
12 Eskelinen M et al. Receiver-operating characteristics (ROC) curve analysis of cathepsin D and pS2 in breast disease; results from a prospective study.
13 Harvima IT et al. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
14 Heino A et al. Application of a self-reinforced polyglycolic acid (SR-PGA) membrane to the closure of an abdominal fascial defect in rats.
15 Hirvikoski P. A Clinicopathological Study on Survival in Laryngeal Squamous Cell Carcinoma. Proteins Related to Adhesion, Cell Proliferation and Apoptosis.
16 Hirvikoski P et al. K-ras and p53 mutations and overexpressions as prognostic factors in female rectal carcinoma.
17 Hirvikoski P et al. Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma.
18 Hirvikoski P et al. Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression.
19 Hirvikoski P et al. Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma.
20 Hirvonen M-R et al. Nitric oxide and proinflammatory cytokines in nasal lavage fluid associated with symptoms and exposure to moldy building microbes.
21 Johansson R. Paraneoplastiset syndroomat.
22 Kaminska R et al. Focal dermal-epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase.
23 Kaminska R et al. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors.
24 Kaminska R et al. Suction blister formation in skin after acute and repeated mast cell degranulation.
25 Karjalainen J. Prognostic Factors of Localized Cutaneous Malignant Melanoma.
26 Karjalainen JM et al. p21 WAF1/CIP1 expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival.
27 Kasanen J-P et al. Evaluation of sensory irritation of delta3-carene and turpentine, and acceptable levels of monoterpenes in occupational and indoor environment.
28 Kataja V, Johansson R. Hormonihoidon perusteet.
29 Kemppainen T et al. Osteoporosis in adult patients with celiac disease.
30 Kemppainen T et al. Bone recovery after a gluten-free diet: a 5-year follow-up study.
31 Kemppainen TA et al. Reply to S Jameson (to Villous atrophy and nutritional status in celiac disease).
32 Keskikuru R et al. Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer.
33 Kivinen PK et al. Quantitative digital image analysis applied to demonstrate the stratified distribution of involucrin in organ cultured human skin.
34 Korpi A et al. Sensory irritating potency of some microbial volatile organic compounds (MVOCs) and a mixture of five MVOCs.
35 Kosma V-M et al. Association of p53, K-ras and proliferating cell nuclear antigen with rat lung lesions following exposure to simulated nuclear fuel particles.
36 Lipponen P. Apoptosis in breast cancer: relationship with other pathological parameters.
37 Liukkonen T et al. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (stage pTa/T1) bladder cancer: a prospective comparative study.
38 Lu S et al. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
39 Långsjö TK et al. Electron microscopic stereological study of collagen fibrils in bovine articular cartilage: volume and surface densities are best obtained indirectly (from length densities and diameters) using isotropic uniform random sampling.
40 Manninen HI et al. Stent placement versus percutaneous transluminal angioplasty of human carotid arteries in cadavers in situ: distal embolization and findings at intravascular US, MR imaging, and histopathologic analysis.
41 Mikkelsson J et al. The GPIIIa P1A polymorphism in the progression of abdominal aortic atherosclerosis.
42 Mikkelsson J et al. Glycoprotein IIIa P1A polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.
43 Mulari M, Johansson R. Syöpä ei tartu, eihän?
44 Romppanen J et al. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
45 Ropponen K. Prognostic Factors in Colorectal Cancer; with Special Reference to Inflammation, Cell Proliferation, Cell Adhesion and Cell Cycle Regulation.
46 Ropponen KM, Alafuzoff I. A case of sudden death caused by fibromuscular dysplasia.
47 Ropponen KM et al. Reduced expression of alfa catenin is associated with poor prognosis in colorectal carcinoma.
48 Ropponen KM et al. p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
49 Setälä LP et al. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate .
50 Syrjänen KJ, Syrjänen SM. Human papillomavirus (HPV) typing as an adjunct to cervical cancer screening.
51 Virtaniemi JA et al. Laterality of laryngeal cancer.
52 Weman SM et al. Post-mortem cast angiography in the diagnostics of graft complications in patients with fatal outcome following coronary artery bypass grafting (CABG).

Kliinisen patologian ja oikeuslääketieteen laitos Department of Pathology and Forensic Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008